Biolife Solutions Inc

BLFS

Exchange: Nasdaq
Industry: Electromedical & Electrotherapeutic Apparatus
SEC CIK: 0000834365

SEC filings (opens in a new tab)

No open-market purchases or sales by Biolife Solutions Inc insiders were filed in the last 90 days; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.40B in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Biolife Solutions Inc changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of BLFS: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Of which not filed for Q4 2021	Q4 2021	Change
Holders	165	1	169	+5
Shares	31.7M	8	35.0M	+3.32M (+10.5%)
Value	$1.34B	$0	$1.31B	−$36.4M (−2.7%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Biolife Solutions Inc at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to BLFS in Q4 2021
Institution	Shares	Value	% of portfolio
Fred Alger Management, LLC	1,695,095	$63.2M	0.16%
Peregrine Capital Management LLC	333,079	$12.4M	0.25%
Stanley-Laman Group, Ltd.	258,638	$9.64M	1.13%
Ergoteles LLC	70,200	$2.62M	0.10%
Parian Global Management LP	55,100	$2.05M	1.86%
Peoples Bank	47,208	$1.76M	0.87%
Tudor Investment Corp Et Al	28,272	$1.05M	0.02%
Yousif Capital Management, LLC	26,192	$976.0K	0.01%
Squarepoint Ops LLC	25,816	$962.0K	0.00%
Meros Investment Management, LP	25,495	$950.0K	0.69%
Pinz Capital Management, LP	16,000	$596.0K	0.23%
Algert Global LLC	12,150	$453.0K	0.06%
D.A. Davidson & Co.	9,850	$367.0K	0.00%
Brinker Capital Investments, LLC	8,380	$312.0K	0.00%
Stansberry Asset Management, LLC	7,397	$276.0K	0.05%
Everence Capital Management Inc	7,260	$271.0K	0.02%
Handelsbanken Fonder AB	6,900	$257.0K	0.00%
Eqis Capital Management, Inc.	6,572	$245.0K	0.02%
Price T Rowe Associates Inc	5,962	$222.0K	0.00%
Cerity Partners LLC	5,671	$212.0K	0.00%
Janus Henderson Group PLC	5,383	$201.0K	0.00%
Aquatic Capital Management LLC	3,400	$127.0K	0.25%
Amundi	3,785	$116.0K	0.00%
Allspring Global Investments Holdings, LLC	2,047	$76.0K	0.00%
Sutton Wealth Advisors Inc.	354	$13.2K	0.00%
FinTrust Capital Advisors, LLC	26	$1.00K	0.00%
Bell Investment Advisors, Inc	12	$0	0.00%

Sold out (22)

Institutions that held Biolife Solutions Inc at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of BLFS in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Wasatch Advisors Inc	477,463	$20.2M
Lisanti Capital Growth, LLC	104,958	$4.44M
Renaissance Technologies LLC	66,600	$2.82M
SG Americas Securities, LLC	30,292	$1.28M
EMC Capital Management	21,878	$1.16M
Canada Pension Plan Investment Board	21,000	$889.0K
M&G Investment Management Ltd	18,348	$771.0K
Crossmark Global Holdings, Inc.	15,800	$669.0K
Verition Fund Management LLC	11,303	$478.0K
Voya Investment Management LLC	9,585	$406.0K
Horan Capital Advisors, LLC.	7,022	$297.0K
Walleye Capital LLC	6,966	$295.0K
Guggenheim Capital LLC	6,628	$280.0K
Paloma Partners Management Co	5,477	$232.0K
Creative Planning	5,000	$212.0K
Sigma Planning Corp	4,850	$205.0K
KBC Group NV	1,100	$47.0K
O'Shaughnessy Asset Management, LLC	929	$39.0K
Cullen/Frost Bankers, Inc.	462	$20.0K
Leonteq Securities AG	41	$1.74K
Fifth Third Bancorp	24	$1.00K
Harbour Investments, Inc.	10	$0

Not filed for Q4 2021 yet (1)

Institutions that held Biolife Solutions Inc at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BLFS in Q3 2021 that haven't filed for Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Berman Capital Advisors, LLC	8	$0